Robert Andrade, CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. (FENC), sold 13,975 shares at $11.00 ($154K) on 2024-03-25, disclosed to the SEC on 2024-03-25.
Scheduled sale ($154k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FENC | SELL | 2024-01-05 | $316K | — | Filing → |
| FENC | SELL | 2023-06-30 | $223K | — | Filing → |
| FENC | SELL | 2022-12-30 | $211K | — | Filing → |